Safety and Feasibility of the Injectable BL-1040 Implant

Clinical trial NCT00557531 · UNKNOWN

Trial details

NCT number: NCT00557531
Sponsor: BioLineRx, Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2008-03-01
Primary completion: 2010-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.